West Pharmaceutical Services (WST) 10-Q2020 Q1 Quarterly report

Filed: 24 Apr 20, 4:04pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: Additionally, admixture, aforesaid, billion, clarifying, closely, CODM, connection, coverage, decision, distribution, downside, driven, duration, environment, established, exceed, exempted, factor, FDA, floating, fluid, good, government, health, identification, imposed, knowledge, largely, length, leverage, lifetime, likelihood, Maker, matrix, maturity, partnership, past, people, percent, phase, precautionary, premium, prevent, preventive, progression, prohibit, projection, promised, reform, remote, response, safety, situation, spread, strong, swap, team, transportation, treasury, turn, unforeseeable, upside, utilized, utilizing, workforce, worldwide

Removed: acquiring, adjust, advance, annualized, annum, apply, assurance, bear, borrow, caption, ceased, cessation, classification, collateralized, combination, commencement, comparative, consistently, controlled, crediting, cumulative, daily, depended, depreciation, direct, domestic, EBITDA, eliminate, Europe, European, expand, expanded, expire, expired, extend, federal, final, finance, fundamental, German, greater, hedged, highest, Holding, iii, implement, implicit, instrument, iv, leasing, lessor, machinery, modify, month, noncancellable, nonfinancial, occurrence, October, outdated, package, pay, permit, portfolio, practical, preceding, prepaid, Prime, qualitative, quantitative, ranging, ratio, reclassification, reclassify, redundant, rental, replaced, retroactively, review, satisfaction, satisfying, scope, securing, senior, separate, standby, stranded, subsequently, subsidiary, swing, terminate, tiered, twelve, unpaid, unsecured, Venezuelan

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Associated WST transcripts

WST similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO SECTION 906 OF

THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of West Pharmaceutical Services, Inc. (the “Company”) for the period ended March 31, 2020, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Bernard J. Birkett, Senior Vice President and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Bernard J. Birkett

Bernard J. Birkett

Senior Vice President and Chief Financial Officer

Date: April 24, 2020